Abbvie Inc. (ABBV) Lobbying Data
ABBV lobbying summary
Abbvie, Inc. (ABBV) has reported $51.6M in federal lobbying spending across 259 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Taxation, Copyright/Patent. Lobbying firms used include Brownstein Hyatt Farber Schreck, LLP, Tarplin, Downs & Young, LLC, Federal Street Strategies, LLC.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $6.4M |
| 2025 | $7.8M |
| 2024 | $6.2M |
| 2023 | $5.3M |
| 2022 | $10.1M |
| 2021 | $8.7M |
See insider trading for ABBV or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.